Home Healthcare Medical Devices Intrauterine Contraceptive Devices Market

Intrauterine Contraceptive Devices Market Size, Share & Trends Analysis Report By Type (Hormonal Intrauterine Devices, Copper Intrauterine Devices), By Product (Mirena, Skyla, Paragard, Essure, Levosert, Others), By End-User (Hospitals, Gynecology Clinics, Community Healthcare Centers) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 04, 2026 | Author: Jay Mehta | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Intrauterine Contraceptive Devices Market, By Type 2022-2034 (USD MILLION/ Units)
    1. Hormonal Intrauterine Devices
    2. Copper Intrauterine Devices
  2. Intrauterine Contraceptive Devices Market, By Product 2022-2034 (USD MILLION/ Units)
    1. Mirena
    2. Skyla
    3. Paragard
    4. Essure
    5. Levosert
    6. Others
  3. Intrauterine Contraceptive Devices Market, By End-User 2022-2034 (USD MILLION/ Units)
    1. Hospitals
    2. Gynecology Clinics
    3. Community Healthcare Centers
  4. Regional Intrauterine Contraceptive Devices Market
    1. North America
      1. North America Intrauterine Contraceptive Devices Market By Type 2022-2034 (USD MILLION/ Units)
        1. Hormonal Intrauterine Devices
        2. Copper Intrauterine Devices
      2. North America Intrauterine Contraceptive Devices Market By Product 2022-2034 (USD MILLION/ Units)
        1. Mirena
        2. Skyla
        3. Paragard
        4. Essure
        5. Levosert
        6. Others
      3. North America Intrauterine Contraceptive Devices Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Gynecology Clinics
        3. Community Healthcare Centers
      4. U.S.
        1. Hormonal Intrauterine Devices
        2. Copper Intrauterine Devices
        3. Mirena
        4. Skyla
        5. Paragard
        6. Essure
        7. Levosert
        8. Others
        9. Hospitals
        10. Gynecology Clinics
        11. Community Healthcare Centers
      5. Canada
        1. Hormonal Intrauterine Devices
        2. Copper Intrauterine Devices
        3. Mirena
        4. Skyla
        5. Paragard
        6. Essure
        7. Levosert
        8. Others
        9. Hospitals
        10. Gynecology Clinics
        11. Community Healthcare Centers
    2. Europe
      1. Europe Intrauterine Contraceptive Devices Market By Type 2022-2034 (USD MILLION/ Units)
        1. Hormonal Intrauterine Devices
        2. Copper Intrauterine Devices
      2. Europe Intrauterine Contraceptive Devices Market By Product 2022-2034 (USD MILLION/ Units)
        1. Mirena
        2. Skyla
        3. Paragard
        4. Essure
        5. Levosert
        6. Others
      3. Europe Intrauterine Contraceptive Devices Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Gynecology Clinics
        3. Community Healthcare Centers
      4. U.K.
        1. Hormonal Intrauterine Devices
        2. Copper Intrauterine Devices
        3. Mirena
        4. Skyla
        5. Paragard
        6. Essure
        7. Levosert
        8. Others
        9. Hospitals
        10. Gynecology Clinics
        11. Community Healthcare Centers
      5. Germany
        1. Hormonal Intrauterine Devices
        2. Copper Intrauterine Devices
        3. Mirena
        4. Skyla
        5. Paragard
        6. Essure
        7. Levosert
        8. Others
        9. Hospitals
        10. Gynecology Clinics
        11. Community Healthcare Centers
      6. France
        1. Hormonal Intrauterine Devices
        2. Copper Intrauterine Devices
        3. Mirena
        4. Skyla
        5. Paragard
        6. Essure
        7. Levosert
        8. Others
        9. Hospitals
        10. Gynecology Clinics
        11. Community Healthcare Centers
      7. Spain
        1. Hormonal Intrauterine Devices
        2. Copper Intrauterine Devices
        3. Mirena
        4. Skyla
        5. Paragard
        6. Essure
        7. Levosert
        8. Others
        9. Hospitals
        10. Gynecology Clinics
        11. Community Healthcare Centers
      8. Italy
        1. Hormonal Intrauterine Devices
        2. Copper Intrauterine Devices
        3. Mirena
        4. Skyla
        5. Paragard
        6. Essure
        7. Levosert
        8. Others
        9. Hospitals
        10. Gynecology Clinics
        11. Community Healthcare Centers
      9. Russia
        1. Hormonal Intrauterine Devices
        2. Copper Intrauterine Devices
        3. Mirena
        4. Skyla
        5. Paragard
        6. Essure
        7. Levosert
        8. Others
        9. Hospitals
        10. Gynecology Clinics
        11. Community Healthcare Centers
      10. Nordic
        1. Hormonal Intrauterine Devices
        2. Copper Intrauterine Devices
        3. Mirena
        4. Skyla
        5. Paragard
        6. Essure
        7. Levosert
        8. Others
        9. Hospitals
        10. Gynecology Clinics
        11. Community Healthcare Centers
      11. Benelux
        1. Hormonal Intrauterine Devices
        2. Copper Intrauterine Devices
        3. Mirena
        4. Skyla
        5. Paragard
        6. Essure
        7. Levosert
        8. Others
        9. Hospitals
        10. Gynecology Clinics
        11. Community Healthcare Centers
      12. Rest of Europe
        1. Hormonal Intrauterine Devices
        2. Copper Intrauterine Devices
        3. Mirena
        4. Skyla
        5. Paragard
        6. Essure
        7. Levosert
        8. Others
        9. Hospitals
        10. Gynecology Clinics
        11. Community Healthcare Centers
    3. APAC
      1. APAC Intrauterine Contraceptive Devices Market By Type 2022-2034 (USD MILLION/ Units)
        1. Hormonal Intrauterine Devices
        2. Copper Intrauterine Devices
      2. APAC Intrauterine Contraceptive Devices Market By Product 2022-2034 (USD MILLION/ Units)
        1. Mirena
        2. Skyla
        3. Paragard
        4. Essure
        5. Levosert
        6. Others
      3. APAC Intrauterine Contraceptive Devices Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Gynecology Clinics
        3. Community Healthcare Centers
      4. China
        1. Hormonal Intrauterine Devices
        2. Copper Intrauterine Devices
        3. Mirena
        4. Skyla
        5. Paragard
        6. Essure
        7. Levosert
        8. Others
        9. Hospitals
        10. Gynecology Clinics
        11. Community Healthcare Centers
      5. Korea
        1. Hormonal Intrauterine Devices
        2. Copper Intrauterine Devices
        3. Mirena
        4. Skyla
        5. Paragard
        6. Essure
        7. Levosert
        8. Others
        9. Hospitals
        10. Gynecology Clinics
        11. Community Healthcare Centers
      6. Japan
        1. Hormonal Intrauterine Devices
        2. Copper Intrauterine Devices
        3. Mirena
        4. Skyla
        5. Paragard
        6. Essure
        7. Levosert
        8. Others
        9. Hospitals
        10. Gynecology Clinics
        11. Community Healthcare Centers
      7. India
        1. Hormonal Intrauterine Devices
        2. Copper Intrauterine Devices
        3. Mirena
        4. Skyla
        5. Paragard
        6. Essure
        7. Levosert
        8. Others
        9. Hospitals
        10. Gynecology Clinics
        11. Community Healthcare Centers
      8. Australia
        1. Hormonal Intrauterine Devices
        2. Copper Intrauterine Devices
        3. Mirena
        4. Skyla
        5. Paragard
        6. Essure
        7. Levosert
        8. Others
        9. Hospitals
        10. Gynecology Clinics
        11. Community Healthcare Centers
      9. Taiwan
        1. Hormonal Intrauterine Devices
        2. Copper Intrauterine Devices
        3. Mirena
        4. Skyla
        5. Paragard
        6. Essure
        7. Levosert
        8. Others
        9. Hospitals
        10. Gynecology Clinics
        11. Community Healthcare Centers
      10. South East Asia
        1. Hormonal Intrauterine Devices
        2. Copper Intrauterine Devices
        3. Mirena
        4. Skyla
        5. Paragard
        6. Essure
        7. Levosert
        8. Others
        9. Hospitals
        10. Gynecology Clinics
        11. Community Healthcare Centers
      11. Rest of Asia-Pacific
        1. Hormonal Intrauterine Devices
        2. Copper Intrauterine Devices
        3. Mirena
        4. Skyla
        5. Paragard
        6. Essure
        7. Levosert
        8. Others
        9. Hospitals
        10. Gynecology Clinics
        11. Community Healthcare Centers
    4. Middle East and Africa
      1. Middle East and Africa Intrauterine Contraceptive Devices Market By Type 2022-2034 (USD MILLION/ Units)
        1. Hormonal Intrauterine Devices
        2. Copper Intrauterine Devices
      2. Middle East and Africa Intrauterine Contraceptive Devices Market By Product 2022-2034 (USD MILLION/ Units)
        1. Mirena
        2. Skyla
        3. Paragard
        4. Essure
        5. Levosert
        6. Others
      3. Middle East and Africa Intrauterine Contraceptive Devices Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Gynecology Clinics
        3. Community Healthcare Centers
      4. UAE
        1. Hormonal Intrauterine Devices
        2. Copper Intrauterine Devices
        3. Mirena
        4. Skyla
        5. Paragard
        6. Essure
        7. Levosert
        8. Others
        9. Hospitals
        10. Gynecology Clinics
        11. Community Healthcare Centers
      5. Turkey
        1. Hormonal Intrauterine Devices
        2. Copper Intrauterine Devices
        3. Mirena
        4. Skyla
        5. Paragard
        6. Essure
        7. Levosert
        8. Others
        9. Hospitals
        10. Gynecology Clinics
        11. Community Healthcare Centers
      6. Saudi Arabia
        1. Hormonal Intrauterine Devices
        2. Copper Intrauterine Devices
        3. Mirena
        4. Skyla
        5. Paragard
        6. Essure
        7. Levosert
        8. Others
        9. Hospitals
        10. Gynecology Clinics
        11. Community Healthcare Centers
      7. South Africa
        1. Hormonal Intrauterine Devices
        2. Copper Intrauterine Devices
        3. Mirena
        4. Skyla
        5. Paragard
        6. Essure
        7. Levosert
        8. Others
        9. Hospitals
        10. Gynecology Clinics
        11. Community Healthcare Centers
      8. Egypt
        1. Hormonal Intrauterine Devices
        2. Copper Intrauterine Devices
        3. Mirena
        4. Skyla
        5. Paragard
        6. Essure
        7. Levosert
        8. Others
        9. Hospitals
        10. Gynecology Clinics
        11. Community Healthcare Centers
      9. Nigeria
        1. Hormonal Intrauterine Devices
        2. Copper Intrauterine Devices
        3. Mirena
        4. Skyla
        5. Paragard
        6. Essure
        7. Levosert
        8. Others
        9. Hospitals
        10. Gynecology Clinics
        11. Community Healthcare Centers
      10. Rest of MEA
        1. Hormonal Intrauterine Devices
        2. Copper Intrauterine Devices
        3. Mirena
        4. Skyla
        5. Paragard
        6. Essure
        7. Levosert
        8. Others
        9. Hospitals
        10. Gynecology Clinics
        11. Community Healthcare Centers
    5. LATAM
      1. LATAM Intrauterine Contraceptive Devices Market By Type 2022-2034 (USD MILLION/ Units)
        1. Hormonal Intrauterine Devices
        2. Copper Intrauterine Devices
      2. LATAM Intrauterine Contraceptive Devices Market By Product 2022-2034 (USD MILLION/ Units)
        1. Mirena
        2. Skyla
        3. Paragard
        4. Essure
        5. Levosert
        6. Others
      3. LATAM Intrauterine Contraceptive Devices Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Gynecology Clinics
        3. Community Healthcare Centers
      4. Brazil
        1. Hormonal Intrauterine Devices
        2. Copper Intrauterine Devices
        3. Mirena
        4. Skyla
        5. Paragard
        6. Essure
        7. Levosert
        8. Others
        9. Hospitals
        10. Gynecology Clinics
        11. Community Healthcare Centers
      5. Mexico
        1. Hormonal Intrauterine Devices
        2. Copper Intrauterine Devices
        3. Mirena
        4. Skyla
        5. Paragard
        6. Essure
        7. Levosert
        8. Others
        9. Hospitals
        10. Gynecology Clinics
        11. Community Healthcare Centers
      6. Argentina
        1. Hormonal Intrauterine Devices
        2. Copper Intrauterine Devices
        3. Mirena
        4. Skyla
        5. Paragard
        6. Essure
        7. Levosert
        8. Others
        9. Hospitals
        10. Gynecology Clinics
        11. Community Healthcare Centers
      7. Chile
        1. Hormonal Intrauterine Devices
        2. Copper Intrauterine Devices
        3. Mirena
        4. Skyla
        5. Paragard
        6. Essure
        7. Levosert
        8. Others
        9. Hospitals
        10. Gynecology Clinics
        11. Community Healthcare Centers
      8. Colombia
        1. Hormonal Intrauterine Devices
        2. Copper Intrauterine Devices
        3. Mirena
        4. Skyla
        5. Paragard
        6. Essure
        7. Levosert
        8. Others
        9. Hospitals
        10. Gynecology Clinics
        11. Community Healthcare Centers
      9. Rest of LATAM
        1. Hormonal Intrauterine Devices
        2. Copper Intrauterine Devices
        3. Mirena
        4. Skyla
        5. Paragard
        6. Essure
        7. Levosert
        8. Others
        9. Hospitals
        10. Gynecology Clinics
        11. Community Healthcare Centers
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.